Comparative Assessment of rEPC1 antigen and Copro-antigen for diagnosis of Echinococcosis in dogs
Authors
Abstract:
Abstract BACKGROUND: Diagnosis of Echinococcus granulosus in the definitive host particularly in dog is the significant complication in the endemic area. OBJECTIVES: The aim of this study is serological detection of E. granulosus in the infected dogs. METHODS: Dot-ELISA based on the copro-antigen and recombinant EPC1 antigen (rEPC1) for antibody detection was performed. Blood and fecal samples were collected from eleven treated poppies with 90000–100000 protoscoleces (90% viability) and four treated poppies with distilled water as controls, on day before challenge and 7, 14, 21, 28 and 35 days post challenges. Furthermore, the blood and fecal samples were collected from 35 naturally infected dogs. RESULTS: In terms of experimentally infected dogs, sensitivity and specificity of Dot- ELISA were close for both antigens (copro- antigen, rEPC1) that were determined to be 100%, 88% for copro–antigen, and 100 and 94% for rEPC1, respectively. In the context of naturally infected dogs, our findings showed similar sensitivity in Dot –ELISA based on the anti-body detection (using rEPC1), and antigen detection (using copro–antigen), (100%), while these methods provided different specificity about 75% for rEPC1 and 58% for copro–antigen. CONCLUSIONS: Our findings indicated that both antigens are qualified. REPC1 antigen is not capable to detect the infection during the first 15 days post-infection, whereas the antibody cannot be detectable. REPC1 protein may work for screening of E. granulosus, while copro-antigen can be useful for diagnosis of current acute infection. However, both methods are recommended for screening of sheepdog, guard dogs and police dogs.
similar resources
Comparison of the Utility of Recombinant B8/2 Subunit of the Antigen B, Native Antigen, and a Commercial ELISA Kit in the Diagnosis of Human Cystic Echinococcosis
Background: Cystic echinococcosis (CE) is a helminthic disease caused by the larval form of Echinococcus granulosus. In the present study, the B8/2 subunit of antigen B (AgB) of E. granulosus was expressed in E. coli host and then applied in a diagnostic ELISA set up. Methods: The DNA sequence of AgB8/2 subunit from E. granulosus was extracted from the GenBank and codon-optimized. The target s...
full textdiagnostic and developmental potentials of dynamic assessment for writing skill
این پایان نامه بدنبال بررسی کاربرد ارزیابی مستمر در یک محیط یادگیری زبان دوم از طریق طرح چهار سوال تحقیق زیر بود: (1) درک توانایی های فراگیران زمانیکه که از طریق برآورد عملکرد مستقل آنها امکان پذیر نباشد اما در طول جلسات ارزیابی مستمر مشخص شوند; (2) امکان تقویت توانایی های فراگیران از طریق ارزیابی مستمر; (3) سودمندی ارزیابی مستمر در هدایت آموزش فردی به سمتی که به منطقه ی تقریبی رشد افراد حساس ا...
15 صفحه اولSignificance of galactomannan antigen for aspergillosis diagnosis: A review
Invasive aspergillosis is one the major causes of death in hematopoietic and solidtransplantrecipients. One of the most critical problems in medical mycology is theinability to consistently make a convincing and early diagnosis of invasive fungalinfection. Conventional diagnosis methods such as culture-based approaches are limitedby the insufficient accessibility sensitivity and the non-culture...
full textassessment of deep word knowledge in elementary and advanced iranian efl learners: a comparison of selective and productive wat tasks
testing plays a vital role in any language teaching program. it allows teachers and stakeholders, including program administrators, parents, admissions officers and prospective employers to be assured that the learners are progressing according to an accepted standard (douglas, 2010). the problems currently facing language testers have both practical and theoretical implications but the first i...
My Resources
Journal title
volume 11 issue 3
pages 217- 225
publication date 2017-08-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023